Designed to promote a healthy lifestyle
Tests for cancer risks with recommendations for prevention and early detection.
-
Coming in 2019
AnteBC
Test for breast cancer risk
AnteBC is a personalised breast cancer risk prediction test. Breast cancer is the most common cancer in women. It provides personalised medical findings regarding the risk of breast cancer and offers recommendations for prevention and early detection.
Suitable for women aged 25–80 who have European ancestry.
Read more -
Coming in 2019
AntePC
Test for prostate cancer risk
Prostate cancer is one of most common malignancies in men. AntePC is a unique test for personalised prostate cancer risk prediction that combines the genetics of polygenic risk scores and monogenic mutations with individual lifestyle risk factors. The test increases men’s awareness of their overall risk of prostate cancer and guides individualised monitoring.
Suitable for men aged 25–80 who have European ancestry.
Read more -
Coming in 2019
AnteCRC
Test for colorectal cancer risk
Colorectal cancer is a common malignancy often with a poor prognosis and a high mortality rate. AnteCRC is a personalised test for assessing the risk of colorectal cancer. It predicts a patient’s risk of colorectal cancer based on a combination of individual polygenic risks, monogenic variations and lifestyle factors.
Suitable for men and women aged 25–80 who have European ancestry.
Read more -
Coming in 2019
AnteMEL
Test for melanoma risk
Melanoma is the most aggressive of skin cancers. If diagnosed early, the disease is treatable. The AnteMEL test is a novel approach to specify personal genetic risks and gives recommendations for individualised screening.
Suitable for men and women aged 25–80 who have European ancestry.
Read more -
Coming in 2019
AnteCancerM
Test for risk of common malignancies in men
A set of tests for prostate cancer, colorectal cancer and melanoma.
Suitable for men aged 25–80 who have European ancestry.
Read more -
Coming in 2019
AnteCancerW
Test for risk of common malignancies in women
A set of tests for breast cancer, colorectal cancer and melanoma.
Suitable for women aged 25–80 who have European ancestry.
Read more
